Atopic Dermatitis

A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.

WASHINGTON — Using dupilumab to treat children with moderate to severe atopic dermatitis proved effective, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The use of a noninvasive skin tape strip at age 2 months can identify infants who are at risk for developing food allergy later, according to a study published in The Journal of Allergy and Clinical Immunology.

As spring begins, patients with tree, grass and weed allergies may have to cope with oral allergy syndrome, which arises from an allergic reaction to certain fresh or raw foods, including vegetables, fruits and nuts, a specialist said.

SAN DIEGO — In this Healio video perspective from the American Academy of Dermatology Annual Meeting, Alphyn Biologics CEO Neal Koller discusses new data from the company’s phase 2a trial of AB-101a for the treatment of atopic dermatitis.

In this Healio exclusive video, Steven R. Feldman, MD, PhD, discussed hidradenitis suppurativa research from the American Academy of Dermatology Annual Meeting, examining two studies into its treatment.

SAN DIEGO — Researchers found that children with moderate to severe atopic dermatitis have a higher mean weight and BMI, but a lower mean height, than healthy children, according to a poster presented here.

SAN DIEGO — Ruxolitinib cream improved quality of life outcomes, including sleep and itch, in children aged 2 to 11 years with atopic dermatitis, according to a poster presented at the American Academy of Dermatology Annual Meeting.

Babies born during the lockdown of March through May 2020 developed significant differences in their microbiome and less atopic dermatitis compared with babies born prior to this period, according to a study published in Allergy.

SAN DIEGO — Children with vs. without atopic dermatitis are more likely to experience learning and memory difficulties, according to a poster presented at the American Academy of Dermatology Annual Meeting.